PCDH10 and pachyonychia congenita: Similarly, a recent study revealed an oncogenic transcription factor FOXM1 which activated expression of miR-552, and further inhibited downstream target genes including Pcdh10, DACH1 and SMAD, which in turn promoted tumor progression and resulted in poor prognosis in PC patients (Wang et al. 2021).